Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series

Background Acquired haemophilia A (AHA) is a rare acquired bleeding disorder that can present with life‐threatening bleeding. Aims To describe recent Australian use of recombinant porcine factor VIII (rpFVIII) replacement therapy as a haemostatic agent in patients with acquired haemophilia. Methods Four patients with acquired haemophilia treated in three different institutions around Australia in the past 12 months were included in the study....